Koninklijke Philips Basic Shares Outstanding 2010-2024 | PHG

Koninklijke Philips annual/quarterly basic shares outstanding history and growth rate from 2010 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
  • Koninklijke Philips basic shares outstanding for the quarter ending September 30, 2024 were $0.933B, a 5.55% increase year-over-year.
  • Koninklijke Philips basic shares outstanding for the twelve months ending September 30, 2024 were $3.669B, a 1.82% increase year-over-year.
  • Koninklijke Philips annual basic shares outstanding for 2023 were $0.917B, a 4.06% increase from 2022.
  • Koninklijke Philips annual basic shares outstanding for 2022 were $0.882B, a 2.51% decline from 2021.
  • Koninklijke Philips annual basic shares outstanding for 2021 were $0.904B, a 0.38% decline from 2020.
Koninklijke Philips Annual Basic Shares Outstanding
(Millions of US $)
2023 $917
2022 $882
2021 $904
2020 $908
2019 $903
2018 $923
2017 $929
2016 $918
2015 $916
2014 $915
2013 $911
2012 $922
2011 $952
2010 $940
2009 $925
Koninklijke Philips Quarterly Basic Shares Outstanding
(Millions of US $)
2024-09-30 $933
2024-06-30 $934
2023-06-30 $920
2023-03-31 $882
2022-06-30 $884
2021-06-30 $907
2020-06-30 $907
2019-06-30 $905
2018-06-30 $917
2017-06-30 $924
2016-12-31 $918
2016-09-30 $925
2016-06-30 $910
2016-03-31 $914
2015-12-31 $916
2015-09-30 $924
2015-06-30 $909
2015-03-31 $912
2014-12-31 $915
2014-09-30 $922
2014-06-30 $908
2014-03-31 $914
2013-12-31 $911
2013-09-30 $914
2013-06-30 $906
2013-03-31 $909
2012-12-31 $918
2012-09-30 $929
2012-06-30 $923
2012-03-31 $923
2011-12-31 $936
2011-09-30 $959
2011-06-30 $964
2011-03-31 $947
2010-12-31 $946
2010-09-30 $946
2010-06-30 $940
2010-03-31 $928
2009-12-31 $927
2009-09-30 $926
2009-06-30 $902
2009-03-31 $923
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.545B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.174B 28.29
Boston Scientific (BSX) United States $155.945B 42.10
Stryker (SYK) United States $148.251B 31.87
EssilorLuxottica (ESLOY) France $140.098B 0.00
Medtronic (MDT) Ireland $111.559B 16.29
Lonza Group Ag (LZAGY) Switzerland $46.232B 0.00
Haleon (HLN) United Kingdom $45.180B 29.35
GE HealthCare Technologies (GEHC) United States $42.309B 20.61
Agilent Technologies (A) United States $39.127B 25.93
ResMed (RMD) United States $34.442B 26.53
Terumo (TRUMY) Japan $26.591B 37.81
Zimmer Biomet Holdings (ZBH) United States $20.572B 12.92
Insulet (PODD) United States $19.899B 79.24
Baxter (BAX) United States $15.736B 10.24
Sunny Optical Technology (SNPTF) China $11.331B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $11.201B 0.00
BellRing Brands (BRBR) United States $9.927B 37.20
Demant (WILYY) Denmark $7.946B 0.00
Bio-Rad Laboratories (BIO) United States $7.944B 27.52
Lantheus Holdings (LNTH) United States $5.659B 13.15
Prestige Consumer Healthcare (PBH) United States $4.205B 20.07
ICU Medical (ICUI) United States $4.019B 38.26
Envista Holdings (NVST) United States $3.747B 29.81
Perrigo (PRGO) Ireland $3.383B 9.96
Haemonetics (HAE) United States $3.198B 15.05
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.913B 19.63
QuidelOrtho (QDEL) United States $2.817B 23.67
LeMaitre Vascular (LMAT) United States $2.319B 56.37
Neogen (NEOG) United States $2.232B 25.73
AtriCure (ATRC) United States $1.907B 0.00
Green Thumb Industries (GTBIF) United States $1.484B 25.89
InMode (INMD) Israel $1.349B 11.28
BioLife Solutions (BLFS) United States $1.296B 0.00
AdaptHealth (AHCO) United States $1.211B 8.65
Maravai LifeSciences Holdings (MRVI) United States $1.030B 0.00
Phibro Animal Health (PAHC) United States $0.979B 15.01
Evolus (EOLS) United States $0.942B 0.00
Curaleaf Holdings (CURLF) Canada $0.918B 0.00
CeriBell (CBLL) United States $0.794B 0.00
Capricor Therapeutics (CAPR) United States $0.686B 0.00
Valneva SE (VALN) France $0.613B 0.00
Omeros (OMER) United States $0.536B 0.00
VAREX IMAGING (VREX) United States $0.529B 22.95
Owens & Minor (OMI) United States $0.527B 4.12
Surmodics (SRDX) United States $0.491B 0.00
SNDL (SNDL) Canada $0.465B 0.00
Cresco Labs (CRLBF) United States $0.438B 0.00
ZimVie (ZIMV) United States $0.368B 31.00
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Verano Holdings (VRNOF) United States $0.341B 0.00
Cerus (CERS) United States $0.336B 0.00
Aurora Cannabis (ACB) Canada $0.318B 57.90
Viemed Healthcare (VMD) United States $0.315B 30.00
Sanara MedTech (SMTI) United States $0.309B 0.00
Quanterix (QTRX) United States $0.301B 0.00
OraSure Technologies (OSUR) United States $0.294B 19.70
Biote (BTMD) United States $0.266B 5.83
Canopy Growth (CGC) Canada $0.260B 0.00
Zynex (ZYXI) United States $0.239B 50.13
Sanuwave Health (SNWV) United States $0.236B 3.31
Brainsway (BWAY) Israel $0.213B 113.20
High Tide (HITI) Canada $0.210B 0.00
Utah Medical Products (UTMD) United States $0.206B 15.40
MacroGenics (MGNX) United States $0.183B 0.00
TriSalus Life Sciences (TLSI) United States $0.174B 0.00
Organigram Holdings (OGI) Canada $0.167B 0.00
TerrAscend (TSNDF) Canada $0.147B 0.00
FitLife Brands (FTLF) United States $0.141B 17.65
Jin Medical (ZJYL) China $0.122B 0.00
Quipt Home Medical (QIPT) United States $0.115B 0.00
Fonar (FONR) United States $0.095B 13.08
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Veru (VERU) United States $0.088B 0.00
InterCure (INCR) Israel $0.073B 0.00
Exagen (XGN) United States $0.068B 0.00
Jushi Holdings (JUSHF) United States $0.068B 0.00
Cytosorbents (CTSO) United States $0.067B 0.00
Rockwell Medical (RMTI) United States $0.060B 30.83
Apyx Medical (APYX) United States $0.056B 0.00
MariMed (MRMD) United States $0.052B 0.00
Hongchang (HCIL) China $0.051B 0.00
United-Guardian (UG) United States $0.049B 14.17
ImmuCell (ICCC) United States $0.046B 0.00
INLIF (INLF) $0.046B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Allurion Technologies (ALUR) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Agape ATP (ATPC) $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00